Non-invasive tests used to stage liver fibrosis in metabolic dysfunction-associated steatohepatitis play a growing role in care and trial recruitment, but their performance in routine practice may differ from results seen in clinical studies.
Non-invasive tests for MASH fall short in clinical practice compared with trials
Non-invasive tests used to stage liver fibrosis in metabolic dysfunction-associated steatohepatitis play a growing role in care and trial recruitment, but their performance in routine practice may differ from results seen in clinical studies.
Fatty liver disease · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.